NCT02181907View on ClinicalTrials.gov

Bioequivalence Study of UH-AC 62 XX Tablets Compared With the Capsule Formulations in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

March 31, 2003

Primary Completion Date

April 30, 2003

Conditions
Healthy
Interventions
DRUG

UH-AC 62 XX tablet

DRUG

UH-AC 62 XX capsule

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY